The ACPi system is the first and only device that is compatible with multiple companies' CSTDs and can be applied to existing anti-cancer manufacturing equipment.

Applying CSTD to ACPi system, an equipment that minimizes raw exposure to anti-cancer drugs with original technology, and ACPi kit set, a consumable product, completely blocks exposure and leakage without using syringes, and fills PCA balloons with anti-cancer drugs or pain suppression drugs with ±0% error at an average of 30~40 rapid preparations and up to 60 preparations per hour is a unique competitiveness that only Anyfusion ACPi system can provide.

In addition, the CSTD developed by existing major companies with plastic can cause exposure and leakage when punching into an infusion bag or vial, and it was quite inconvenient as an adapter that pharmacists and nurses use and struggle with the most. The patented MCST1 and 2 adapter developed by the company as a needle solves these problems and has been well received by the best national universities and private universities in Korea and is being considered for priority use. This result is expected to be quite competitive in the global market.

For this reason, Company S, which owns the safest and most expensive patent for CSTD, sent a formal warning letter to MCST to remove the material comparing MCST and Company S's CSTD on its website immediately or face legal action. Company S confirmed the excellence of Anyfusion Quick ACPi system at the exhibition of the Korean Hospital Pharmacy Association Fall Conference and requested to negotiate a strategic partnership for global market sales.

Company S's CSTD supply conditions and strategic collaboration with Anyfusion Quick ACPi system are expected to create synergy to activate the global market.

Thank you.